Overview

Evaluation of Efficacy and Safety of Levocetirizine to Subjects With Perennial Allergic Rhinitis to House Dust Mites

Status:
Completed
Trial end date:
2003-05-01
Target enrollment:
Participant gender:
Summary
Evaluation of Efficacy and Safety of Levocetirizine to Subjects With Perennial Allergic Rhinitis to House Dust Mites
Phase:
Phase 4
Details
Lead Sponsor:
UCB Pharma
Treatments:
Cetirizine
Levocetirizine